BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID AND Diagnosis
8 results:

  • 1. Role of Immune Microenvironment in pancreatic Ductal Adenocarcinoma: Could It Be Considered a Predictor of Prognosis?
    De Simoni O; Dal Santo L; Scarpa M; Munari G; Spolverato YC; Scapinello A; Lonardi S; Soldà C; Bergamo F; Fantin A; Bardini R; Pilati P; Fassan M; Gruppo M
    Curr Oncol; 2023 Jun; 30(6):5515-5528. PubMed ID: 37366900
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Association of Sarcopenia with a Poor Prognosis and Decreased Tumor-Infiltrating CD8-Positive T Cells in pancreatic Ductal Adenocarcinoma: A Retrospective Analysis.
    Masuda S; Yamakawa K; Masuda A; Toyama H; Sofue K; Nanno Y; Komatsu S; Omiya S; Sakai A; Kobayashi T; Tanaka T; Tsujimae M; Ashina S; Gonda M; Abe S; Uemura H; Kohashi S; Inomata N; Nagao K; Harada Y; Miki M; Irie Y; Juri N; Kanzawa M; Itoh T; Fukumoto T; Kodama Y
    Ann Surg Oncol; 2023 Sep; 30(9):5776-5787. PubMed ID: 37191859
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The Effects of Treatment on Peripheral Blood Immune Cell Profile in pancreatic Ductal Adenocarcinoma (PDAC).
    Tulyte S; Characiejus D; Matuzeviciene R; Janiulioniene A; Radzevicius M; Zvirblis T; Sileikis A
    Anticancer Res; 2022 Jun; 42(6):3067-3073. PubMed ID: 35641268
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer.
    Pu N; Zhao G; Yin H; Li JA; Nuerxiati A; Wang D; Xu X; Kuang T; Jin D; Lou W; Wu W
    J Transl Med; 2018 Oct; 16(1):294. PubMed ID: 30359281
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. MUC16 C terminal-induced secretion of tumor-derived IL-6 contributes to tumor-associated Treg enrichment in pancreatic cancer.
    Fan K; Yang C; Fan Z; Huang Q; Zhang Y; Cheng H; Jin K; Lu Y; Wang Z; Luo G; Yu X; Liu C
    Cancer Lett; 2018 Apr; 418():167-175. PubMed ID: 29337110
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The similarity of Type 1 autoimmune pancreatitis to pancreatic ductal adenocarcinoma with significant IgG4-positive plasma cell infiltration.
    Fukui Y; Uchida K; Sumimoto K; Kusuda T; Miyoshi H; Koyabu M; Ikeura T; Sakaguchi Y; Shimatani M; Fukui T; Matsushita M; Takaoka M; Nishio A; Shikata N; Sakaida N; Uemura Y; Satoi S; Kwon AH; Okazaki K
    J Gastroenterol; 2013 Jun; 48(6):751-61. PubMed ID: 23053421
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Usefulness of endoscopic biopsy using foxp3+ Treg up-regulation in the duodenal papilla in the differential diagnosis between autoimmune pancreatitis and pancreatic cancer.
    Kubota K; Kato S; Watanabe S; Fujita K; Yoneda M; Takahashi H; Inamori M; Shimamura T; Kirikoshi H; Kobayashi N; Saito S; Hisatomi K; Matsuhashi N; Nakajima A
    J Hepatobiliary Pancreat Sci; 2011 May; 18(3):414-21. PubMed ID: 21113630
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Intraductal papillary mucinous neoplasia (IPMN). Highlights from the "2010 ASCO Gastrointestinal cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
    Bussom S; Saif MW
    JOP; 2010 Mar; 11(2):131-4. PubMed ID: 20208320
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.